Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
1.750
-0.070 (-3.85%)
Mar 31, 2025, 1:39 PM EDT - Market open
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $592.69 million as of March 31, 2025. Its market cap has increased by 12.27% in one year.
Market Cap
592.69M
Enterprise Value
90.44M
1-Year Change
12.27%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $592.69M, an increase of 239.69%. That is a compound annual growth rate of 30.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 616.40M | -31.15% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | 210.45M | 20.62% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |